United States Biotechnology & Medical Research

Longboard Pharmaceuticals Inc (LBPH)

Track

Ticker: LBPH Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
434.87
Quantity 251 +39.2%
Value US$1,442,163
1.0
RANDALL KAYE Officer Officer
Transaction date
Proposed sale
Price
414.40
Quantity 68,727
Value US$4,359,639
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
196.37
Quantity 15,873 -15.8%
Value US$1,748,223
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
33.12
Quantity 1,200 -5.7%
Value US$39,750
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
31.81
Quantity 4,200 -16.7%
Value US$133,622
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
30.89
Quantity 9,366 -27.1%
Value US$289,278
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
35.03
Quantity 6,191 -25.7%
Value US$216,856
1.0
Kaye Randall CMO Officer
Transaction date
Planned sale
Price
34.55
Quantity 10,476 -30.3%
Value US$361,948
1.0
RANDALL KAYE Officer Officer
Transaction date
Proposed sale
Price
35.09
Quantity 16,667
Value US$584,845
1.0
Kaye Randall CMO Officer
Transaction date
Sale
Price
20.87
Quantity 100 -100.0%
Value US$2,087
3.0
ARENA PHARMACEUTICALS INC Former 10% Owner
Transaction date
Sale
Price
24.25
Quantity 3,978,540 -100.0%
Value US$96,479,595
1.0
Kaye Randall CMO Officer
Transaction date
Purchase
Price
24.82
Quantity 100 +inf%
Value US$2,482
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-16 2024-10-15 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
251 +39.2%
434.87
US$1,442,163 		251 +39.2% 434.87 US$1,442,163
2024-09-16 2024-09-16 PrS Proposed sale
1.0
RANDALL KAYE

Officer

Officer
68,727
414.40
US$4,359,639 		68,727 414.40 US$4,359,639
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
15,873 -15.8%
196.37
US$1,748,223 		15,873 -15.8% 196.37 US$1,748,223
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
1,200 -5.7%
33.12
US$39,750 		1,200 -5.7% 33.12 US$39,750
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
4,200 -16.7%
31.81
US$133,622 		4,200 -16.7% 31.81 US$133,622
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
9,366 -27.1%
30.89
US$289,278 		9,366 -27.1% 30.89 US$289,278
2024-08-13 2024-08-12 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
6,191 -25.7%
35.03
US$216,856 		6,191 -25.7% 35.03 US$216,856
2024-08-13 2024-08-12 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
10,476 -30.3%
34.55
US$361,948 		10,476 -30.3% 34.55 US$361,948
2024-08-12 2024-08-12 PrS Proposed sale
1.0
RANDALL KAYE

Officer

Officer
16,667
35.09
US$584,845 		16,667 35.09 US$584,845
2024-08-13 2024-06-25 S Sale
1.0
Kaye Randall

CMO

Officer
100 -100.0%
20.87
US$2,087 		100 -100.0% 20.87 US$2,087
2024-01-29 2024-01-25 S Sale
3.0
ARENA PHARMACEUTICALS INC

Former 10% Owner
3,978,540 -100.0%
24.25
US$96,479,595 		3,978,540 -100.0% 24.25 US$96,479,595
2024-08-13 2024-01-23 B Purchase
1.0
Kaye Randall

CMO

Officer
100 +inf%
24.82
US$2,482 		100 +inf% 24.82 US$2,482
Explore more

More insider trading research around Longboard Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America